SLU-PP-332

SLU-PP-332 Capsules – 250mcg (60 Capsules)

SLU-PP-332 is a small-molecule research compound referenced within advanced laboratory and preclinical research investigating estrogen-related receptor (ERR) signalling pathways, particularly ERRα, ERRβ, and ERRγ nuclear receptor activity associated with mitochondrial function and cellular energy regulation.

Within controlled experimental systems, SLU-PP-332 has been studied as a selective ERR pathway modulator, making it a compound of interest in research exploring transcriptional regulation of genes involved in oxidative metabolism, mitochondrial biogenesis, and cellular bioenergetics.

Published laboratory and preclinical research has examined SLU-PP-332 in relation to:

• Estrogen-related receptor (ERRα, ERRβ, ERRγ) signalling pathways

• Transcriptional regulation of mitochondrial and oxidative metabolism genes

• Cellular energy expenditure and metabolic signalling frameworks

• Mitochondrial biogenesis and respiratory function in vitro

• Experimental models of oxidative phosphorylation and metabolic adaptation

As an ERR-targeting research compound, SLU-PP-332 provides a tool for investigating nuclear receptor–mediated transcriptional networks and their role in cellular energy homeostasis and mitochondrial efficiency within controlled laboratory environments.

Its role in ERR signalling research has positioned SLU-PP-332 as a compound of interest within advanced metabolic and bioenergetic research programmes focused on transcriptional control and mitochondrial function.

Each capsule contains 250mcg of SLU-PP-332, supplied in a convenient vegetable capsule format for precise handling in research applications.

Product Specifications:

• 250mcg per capsule

• 60 capsules per container

• Vegetable-based capsules

• High-purity compound

• Manufactured in controlled facilities

Disclaimer

This product is supplied strictly for laboratory and research purposes only.

Not for human consumption, medical, diagnostic, or therapeutic use.